Signals and transcription factors involved in B-cell PD-1 induction.

Slides:



Advertisements
Similar presentations
Cell Physiol Biochem 2017;42:2582– DOI: /
Advertisements

Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the.
Activation of Human Neutrophil by Cytokine-Activated Endothelial Cells
Expression of immune checkpoint molecules on leukocytes and tumor cells at baseline and in response to selinexor. Expression of immune checkpoint molecules.
High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells  Bo Wang, PhD, Fei Li, MD, Chao Zhang, PhD,
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells by Rossana Trotta, David Ciarlariello, Jessica Dal Col, Hsiaoyin Mao,
Nickel Sulfate Promotes IL-17A Producing CD4+ T Cells by an IL-23-Dependent Mechanism Regulated by TLR4 and Jak-STAT Pathways  Rami Bechara, Diane Antonios,
Adult Aortic Valve Interstitial Cells Have Greater Responses to Toll-Like Receptor 4 Stimulation  Xin-Sheng Deng, MD, Xianzhong Meng, MD, PhD, QingChun.
Nickel Sulfate Promotes IL-17A Producing CD4+ T Cells by an IL-23-Dependent Mechanism Regulated by TLR4 and Jak-STAT Pathways  Rami Bechara, Diane Antonios,
PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation. PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation.
Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
Volume 24, Issue 5, Pages (May 2006)
Nod2-Induced Autocrine Interleukin-1 Alters Signaling by ERK and p38 to Differentially Regulate Secretion of Inflammatory Cytokines  Matija Hedl, Clara.
Attenuated MDSC-suppressive activity and metastasis development in IDO-deficient mice is rescued by IL-6. Attenuated MDSC-suppressive activity and metastasis.
Combined inhibition of MAP kinase and KIT signaling destabilizes ETV1 protein and results in enhanced growth suppression of human GIST cells. Combined.
M.A. Greene, R.F. Loeser  Osteoarthritis and Cartilage 
Triggering PD-1 in B cells suppresses tumor-specific immunity and promotes disease progression. Triggering PD-1 in B cells suppresses tumor-specific immunity.
LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia by Hongwei Qin, Cynthia A. Wilson, Sun Jung Lee,
MD-2s fails to mediate LPS-dependent NF-κB activation and IL-8 secretion. MD-2s fails to mediate LPS-dependent NF-κB activation and IL-8 secretion. A,
RAS/RAF pathway-activated ovarian cancer cells exhibit MEK dependence and synergistic induction of apoptosis with combined MEK/AKT inhibition. RAS/RAF.
H31m1-PDL1 cells form progressively growing tumors in WT mice.
Volume 20, Issue 1, Pages 3-5 (July 2011)
NF1 downregulation activates MAPK pathway signaling.
ABIN-1 inhibits IL-17–dependent NF-κB activation.
PD-1 expression on HCC-infiltrating B cells and its clinical significance. PD-1 expression on HCC-infiltrating B cells and its clinical significance. A–H,
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells by Mia Eriksson, Pablo Peña-Martínez,
Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.
Volume 40, Issue 5, Pages (May 2014)
Imipramine and promethazine induce the apoptotic cell death of SCLC cells through activation of caspase-3. Imipramine and promethazine induce the apoptotic.
Figure 1 Fingolimod does not alter human monocyte viability Peripheral blood mononuclear cells from healthy donors were briefly exposed to increasing concentrations.
Volume 10, Issue 3, Pages (September 2006)
Inhibition of β-catenin by the Smad4/BMP pathway.
by Defne Bayik, Debra Tross, Lydia A
Role of TLR signaling in hY4-induced changes and effects of TLR inhibition. Role of TLR signaling in hY4-induced changes and effects of TLR inhibition.
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
AKT2, but not AKT1, is required for regulating survival of PTEN-deficient prostate tumor spheroids. AKT2, but not AKT1, is required for regulating survival.
by Rodrigo Abreu, Frederick Quinn, and Pramod K. Giri
Caspase 8 is expressed in human ESCs but is not regulated by IFN-γ, TNF-α or hCG. Caspase 8 is expressed in human ESCs but is not regulated by IFN-γ, TNF-α.
Highly related T9 and T3 sarcoma cells show distinct tumor growth patterns but similar PD-L1 expression kinetics in vivo. Highly related T9 and T3 sarcoma.
Figure 2 Fingolimod impairs induction of activation markers on human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed.
Figure 3 Fingolimod inhibits TNF-α secretion by human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed to increasing.
IL-27 induces expression of multiple IR by CD8+ T cells.
Fig. 2. Inhibition of insulin-like growth factor (IGF)-1-induced (pro)inflammatory cytokines of SZ95 sebocytes by eupatilin. With the exception of the.
JAK inhibitors suppress IL-17–induced expression of IκB-ζ.
Figure 5 TLR-dependent signaling pathways inhibited by glatiramer acetate Myeloid differentiation primary response gene 88 (MyD88) and Toll-IL-1 receptor.
PTENP1 sensitizes renal cancer cells to chemotherapy.
Induction of CDCP1 is regulated by Ras in NSCLC cells.
CD49b+ cells from tumor-bearing mice are more prone to conversion into MDSCs compared with naive CD49b+ cells. CD49b+ cells from tumor-bearing mice are.
pDCs from the melanoma environment responded to TLR-L stimulation.
Inhibition of stress-associated MAPK signaling attenuates SASP expression in CAFs. A, N-CAFs were treated with 100 nmol/L GEM plus DMSO or the above-listed.
Bcl-2 and caspase inhibition fails to inhibit BAMLET-induced cytotoxicity in MCF-7 cells. Bcl-2 and caspase inhibition fails to inhibit BAMLET-induced.
PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination. PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination.
Role of MAPKs on DPP-23-induced autophagy and apoptosis.
FcRγ signaling regulates BTK activation and mediates PDAC growth.
IGF-I partially protects Rh30 cells from apoptosis despite simultaneous inhibition of PI3K-Akt and MAP kinase pathways. IGF-I partially protects Rh30 cells.
Prostaglandin E2 attenuates the host antitumor immunity to promote the HFD-induced HCC development. Prostaglandin E2 attenuates the host antitumor immunity.
PD-1 and CD103 are coexpressed on CD8+ T cells but demonstrate distinct mechanisms of regulation. PD-1 and CD103 are coexpressed on CD8+ T cells but demonstrate.
Pdcd4 expression inhibits AP-1 transactivation.
Combined inhibition of coamplified RTKs is required for response.
LPS inhibits polyI:C-induced proinflammatory cytokines in human DCs
Monocytes from melanoma patients are unresponsive to TLR3 agonists.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Phenotypic and functional characteristics of PD-1hi B cells in HCC tissue. Phenotypic and functional characteristics of PD-1hi B cells in HCC tissue. A,
Induction of PD-1 in B cells by TLR agonists and primary HCC-SN.
IL-17 signaling upregulates ABIN-1 mRNA but downregulates protein.
CD36 expression in tissue adjacent and distal to the tumor.
Inhibition of BCR-mediated signaling by ARQ 531.
PD-L1 expression is not associated with PTEN expression status in melanomas. PD-L1 expression is not associated with PTEN expression status in melanomas.
The inverse correlation between PARP1 and PD-L1, PAR, and p-STAT3 expression in surgical specimens of ovarian cancer. The inverse correlation between PARP1.
Presentation transcript:

Signals and transcription factors involved in B-cell PD-1 induction. Signals and transcription factors involved in B-cell PD-1 induction. A, FACS analysis of BCL6 expression in PD-1−, PD-1dim, and PD-1hi B cells from HCC tumor tissue. Results show mean ± SEM of B cells from four patients. B, FACS analysis of STAT6 activation status in HCC tumor B cells (N = 4), with peripheral B cells treated with 10 ng/mL IL4 for 15 minutes as a positive control. C and D, B cells from healthy blood donors were left untreated or exposed to primary HCC-SN (C), or exposed to various TLR agonists or cytokines (D) for 48 hours. Thereafter, BCL6 expression and STAT6 activation were determined by immunoblotting. Results represent four independent experiments (N = 5). E and F, using a pSIF-H1-CopGFP-shBCL6 lentiviral vector to silence BCL6 largely attenuated the HCC-SN–mediated induction of PD-1+/hi B cells (E), and knockdown of STAT6 effectively rescued the IL4-elicited PD-1 inhibition (F). Data are given as mean ± SEM of four independent experiments (N = 5 for E, N = 4 for F). G, primary HCC-SN induced vigorous activation of AKT, MAPKs, and NFκB in healthy blood B cells. Results represent three independent experiments (N = 4). H, inhibition of JNK, NFκB, and p38 suppressed B-cell BCL6 expression and subsequent PD-1 expression induced by primary HCC-SN. Data are given as mean ± SEM of three independent experiments (N = 4). Statistics were compared with DMSO controls. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Student t test). Xiao Xiao et al. Cancer Discov 2016;6:546-559 ©2016 by American Association for Cancer Research